Unveiling PHF19: A Novel Prognostic Biomarker and Candidate Therapeutic Node in Pheochromocytoma and Paraganglioma
This study establishes PHF19 as a potential prognostic indicator and immunotherapy target in PCPG, highlighting its immunomodulatory potential and the need to validate its therapeutic value functionally. Subsequent studies should focus on corroborating these results in broader cohorts and on probing the therapeutic prospects of targeting PHF19 in PCPG.
Authors
- Dongbing Li
- Yanjin Li (ORCID: https://orcid.org/0000-0002-6750-6693)
Institutions
- Dongguan University of Technology (CN)
- Dongguan People’s Hospital (CN)
- Precision Research (United States) (US)
Publication Details
- Journal
- Current Topics in Medicinal Chemistry
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2174/0115680266425775251128104329
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00